SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Settlemen Regulatory News (LSAA)

Share Price Information for Life Settlemen (LSAA)

Share Price is delayed by 15 minutes
Get Live Data
1.795    0.00 (0.00%)
Bid:
1.77
Ask:
1.82
Spread: 0.05 (2.825%)
Market Cap: $75.42m
LSAA Live PriceLast checked at - London Stock Exchange

Intraday Life Settlemen Share Chart

Directorate Change and new Board structure

22 Dec 2020 07:00

RNS Number : 4562J
Life Settlement Assets PLC
22 December 2020
 

LIFE SETTLEMENT ASSETS PLC

(the "Company" or "LSA")

LEI: 2138003OL2VBXWG1BZ27

 

Life Settlement Assets announces new Board structure

The Board of LSA, the listed closed-ended investment company, announces the new structure of its Board as previously indicated in the Company's half year report to 30 June 2020.

Yves Mertz and Robert Edelstein will step down as Directors from the Board with effect from 31 December 2020. Both will continue to advise the Board in their capacity as representatives of two of our key service providers.

LSA previously announced the departure of Franck Mathe, who retired as a Director of the Company on 30 September 2020 after serving on the Board (and the predecessor company) for many years.

Accordingly, the Board will now consist of Michael Baines (Chairman), Guner Turkmen and Christopher Casey, all of whom are non-executive and independent of both the investment manager, Acheron Capital Limited and of LSA's service providers.

The Board does not intend to recruit additional Board members at present.

Michael Baines, Chairman of the Board, commented:

"We are grateful for the long-standing support that Yves and Robert have given to LSA and its predecessor company and we are pleased that they will continue to advise the business and the Board.

This further normalisation of our governance structure is more appropriate for the size of our company, maintains support from our service providers and, is in line with our strategic direction."

22 December 2020

 

For further information contact

Acheron Capital Limited (Investment Manager)Jean-Michel Paul020 7258 5990

Shore Capital (Financial Adviser and Broker)Robert Finlay020 7408 4090

ISCA Administration Services LimitedCompany SecretaryTel: 01392 487056

 

Notes to Editors

 

Life Settlement Assets PLC is a closed-ended investment trust company which invests in, and manages, portfolios of whole and fractional interests in life settlement policies issued by life insurance companies operating predominantly in the United States. The Company seeks to generate long-term returns for investors by investing in the life settlement market, through each of the separate Share Classes. The Company aims to manage its investment in portfolios of life settlement products so that the realised value of the policy maturities exceeds the aggregate cost of acquiring the policies, ongoing premiums, management fees and other operational costs.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZMZZGZNGGZG
Date   Source Headline
9th Jun 20266:13 pmRNSResult of AGM
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20262:56 pmRNSNet Asset Value(s)
1st Jun 20269:21 amRNSTotal Voting Rights
26th May 20269:08 amRNSTransaction in Own Shares
18th May 20269:11 amRNSTransaction in Own Shares
12th May 20268:06 amRNSTransaction in Own Shares
11th May 20267:25 amRNSTransaction in Own Shares
7th May 20266:10 pmRNSTransaction in Own Shares
7th May 20268:23 amRNSTransaction in Own Shares
6th May 20261:50 pmRNSNet Asset Value(s)
5th May 20268:54 amRNSTransaction in Own Shares
1st May 20263:30 pmRNSTotal Voting Rights
28th Apr 20265:42 pmRNSTransaction in Own Shares
28th Apr 20267:00 amRNSFinal Results
22nd Apr 20268:13 amRNSTransaction in Own Shares
13th Apr 20261:42 pmRNSNet Asset Value(s)
1st Apr 20268:19 amRNSTotal Voting Rights
25th Mar 20267:00 amRNSNet Asset Value(s)
20th Mar 202611:20 amRNSTransaction in Own Shares
19th Mar 20268:52 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSShare Buyback Programme
16th Mar 20267:00 amRNSShare Buyback Programme
9th Mar 20267:02 amRNSNet Asset Value(s)
9th Mar 20267:00 amRNSPortfolio Update
7th Jan 20265:46 pmRNSNet Asset Value(s)
18th Dec 20255:46 pmRNSNet Asset Value(s)
27th Nov 20257:00 amRNSAppointment of Corporate Broker
11th Nov 20252:23 pmRNSNet Asset Value(s)
7th Oct 20251:57 pmRNSNet Asset Value(s)
29th Sep 20257:00 amRNSResults for the Half Year ended 30 June 2025
29th Aug 20251:00 pmRNSNet Asset Value(s)
31st Jul 20259:50 amRNSNet Asset Value(s)
4th Jul 20254:06 pmRNSNet Asset Value(s)
1st Jul 20259:33 amRNSTotal Voting Rights
26th Jun 20255:32 pmRNSDirector Declaration
25th Jun 20257:00 amRNSPortfolio Update
18th Jun 20252:47 pmRNSAGM Statement
18th Jun 202511:23 amRNSNet Asset Value(s)
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 202511:55 amRNSNet Asset Value(s)
2nd Jun 202510:51 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
1st May 202512:21 pmRNSNet Asset Value(s)
1st May 202512:12 pmRNSNet Asset Value(s)
1st May 20259:23 amRNSTotal Voting Rights
29th Apr 20257:00 amRNSFinal Results
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.